An overview of salsalate as a potential antidiabetic therapy

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The incidence of type 2 diabetes is increasing at an alarming rate throughout the world. This is in large part due to the increase in obesity and the aging of the population. Therefore, new medications to combat type 2 diabetes are needed. Salicylates have been used as analgesics and antiinflammatory agents for several decades. Incidentally, in some studies it was noted that high-dose salicylate treatment reduced blood glucose concentrations. Recently, inflammation has been strongly associated with insulin resistance and diabetes. Some studies show that salsalate, which is a nonacetylated form of salicylate, reduces blood glucose concentrations in patients with type 2 diabetes, as well as in insulin-resistant patients without diabetes. Postulated mechanisms include the inhibition of nuclear factor NF-kappa-B. Discussed in this review are the efficacy, safety and mechanisms of salsalate relevant to the treatment of type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)847-853
Number of pages7
JournalDrugs of Today
Issue number11
StatePublished - Nov 2010

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'An overview of salsalate as a potential antidiabetic therapy'. Together they form a unique fingerprint.

Cite this